[Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)].
作者信息
Shimoyama M
出版信息
Nihon Ketsueki Gakkai Zasshi. 1974 Oct;37(5):695-706.
PMID:4480564
Abstract
摘要
相似文献
1
[Strategy of antileukemic agents; the relationship between in vitro cell-killing kinetics and in vivo chemotherapeutic effects (author's transl)].[抗白血病药物的策略；体外细胞杀伤动力学与体内化疗效果之间的关系（作者译）]
Nihon Ketsueki Gakkai Zasshi. 1974 Oct;37(5):695-706.
2
Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.羟基脲对培养的增殖性白血病L1210细胞活力影响的动力学评估
J Natl Cancer Inst. 1970 Jan;44(1):201-9.
3
[Experimental basis of combination chemotherapy in the treatment of acute leukemia (author's transl)].联合化疗治疗急性白血病的实验基础（作者译）
Nihon Ketsueki Gakkai Zasshi. 1974 Oct;37(5):731-9.
4
A methodological approach to the prediction of anticancer drug effect in humans.一种预测抗癌药物对人体疗效的方法学途径。
Cancer Res. 1979 Feb;39(2 Pt 1):402-7.
5
The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
Cancer Res. 1973 Apr;33(4):895-901.
6
Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.小鼠晚期白血病L1210中抗白血病药物的评价。X。
Cancer Chemother Rep 2. 1972 Nov;3(1):1-69.
7
Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.使用小鼠晚期白血病L1210对抗白血病药物的评估。VII.
Cancer Res. 1964 Jan;24(1 Pt 1):145-210.
8
Analysis of tests of chemotherapeutic agents involving repeated drug treatment.涉及重复药物治疗的化疗药物测试分析。
Biometrics. 1973 Dec;29(4):677-93.
9
10
Biochemical rationales for the selection of combinations of chemotherapeutic agents.
Cancer Chemother Rep 2. 1974 Mar;4(1):131-6.
引用本文的文献
1
Pre-operative intra-arterial chemotherapy for bladder cancer.
Urol Res. 1981;9(6):289-95. doi: 10.1007/BF00257778.
Zotero 插件